Cited by 158Neurotransmitter Receptor Influence on BehaviorNeural and Behavioral Psychology StudiesNeuroscience and Neuropharmacology Research

Relative roles of ventral striatal D1 and D2 dopamine receptors in responding with conditioned reinforcement

Wolterink, G., Phillips, G., Cador, M., Donselaar-Wolterink, I., Robbins, T. W., Everitt, B. J.·1993·Psychopharmacology

Abstract

Several experiments investigated the involvement of D1 and D2 dopamine receptors in the ventral striatum in the control over behaviour by a conditioned reinforcer using an acquisition of new response procedure. Intra-accumbens infusion of either the D1 receptor antagonist, SCH 23390, or the D2 receptor antagonist, raclopride, completely blocked the potentiative effects of intra-accumbens d-amphetamine on responding with conditioned reinforcement and reduced responding to control levels. SCH 23390 was more potent than raclopride. At higher doses in the absence of d-amphetamine, both antagonists also blocked the preference for responding on the lever producing the conditioned reinforcer. Intra-accumbens infusions of either the D1 receptor agonist, SKF 38393, or the D2/3 receptor agonist, LY 171555 (quinpirole), selectively potentiated responding on the lever producing the conditioned reinforcer. Various combined infusions of the D1 and D2 agonists in specific low doses had additive, but not synergistic, effects on responding with conditioned reinforcement. None of the drugs affected the drinking of water in deprived subjects when infused intra-accumbens. These results suggest that both D1 and D2 receptors in the nucleus accumbens are involved in mediating the effects of dopamine in potentiating the control over behaviour by conditioned reinforcers.

Integrity signals

Registry

Crossref · 10.1007/bf02251293

Cites

54 of 54 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Intra-accumbens injections of dopamine receptor antagonists or 6-OHDA treatments abolish conditioned reinforcement and attenuate amphetamine-enhanced conditioned reinforcement.

    “Furthermore, intra-accumbens injections of dopamine receptor antagonists or 6-OHDA treatments abolishes conditioned reinforcement (Robbins and Everitt, 1982) and attenuate amphetamine-enhanced conditioned reinforcement (Taylor and Robbins, 1986; Wolterink et al., 1993).”

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Wolterink, G., Phillips, G., Cador, M., Donselaar-Wolterink, I., Robbins, T. W., & Everitt, B. J.
Affiliations
  • University of Cambridge (GB)
  • Inserm (FR)
Venue
Psychopharmacology
Published
1993-02
Volume
110
Issue
3
Pages
355-364
ISSN
  • 0033-3158 (ISSN-L)
  • 1432-2072
OpenAlex
W2021496139
Cited by
158
References
54
Citations by year
2025: 3 · 2022: 3 · 2021: 1 · 2020: 2 · 2019: 2 · 2018: 3 · 2016: 4 · 2015: 3 · 2014: 5 · 2013: 2 · 2012: 1
FWCI
2.16
Type
journal article
Language
en
Open access
closed
Locations
  • Psychopharmacology (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
  • Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
  • Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neuroscience and Neuropharmacology Research
Keywords
dopamine D1 receptor, dopamine D2 receptor, ventral striatum, nucleus accumbens, conditioned reinforcement, d-amphetamine, SCH 23390, raclopride, SKF 38393, quinpirole, dopamine agonists, dopamine antagonists
MeSH terms
Animals, Conditioning, Operant, Dextroamphetamine, Dose-Response Relationship, Drug, Ergolines, Male, Nucleus Accumbens, Reinforcement, Psychology, Salicylamides, 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine, Neostriatum, Receptors, Dopamine D1, Receptors, Dopamine D2, Dopamine Agonists, Dopamine Antagonists, Quinpirole, Raclopride, Rats

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review